Centro de Investigación Biomédica en Red sobre Epidemiología Y Salud Pública -ko ikertzaileekin lankidetzan egindako argitalpenak (48)

2023

  1. Consensus on post COVID in the Spanish national health system: Results of the CIBERPOSTCOVID eDelphi study

    Journal of Infection and Public Health, Vol. 16, Núm. 11, pp. 1784-1792

  2. Factors associated with salbutamol overuse in bronchiolitis

    European Journal of Pediatrics, Vol. 182, Núm. 9, pp. 4237-4245

  3. Traumatic stress symptoms among Spanish healthcare workers during the COVID-19 pandemic: a prospective study

    Epidemiology and psychiatric sciences, Vol. 32, pp. e50

2022

  1. Corrigendum: Dynamics of Emergency Cardiovascular Hospital Admissions and In-Hospital Mortality During the COVID-19 Pandemic: Time Series Analysis and Impact of Socioeconomic Factors, (Front. Cardiovasc. Med, (2022), 9, (827212), 10.3389/fcvm.2022.827212)

    Frontiers in Cardiovascular Medicine

  2. Dynamics of Emergency Cardiovascular Hospital Admissions and In-Hospital Mortality During the COVID-19 Pandemic: Time Series Analysis and Impact of Socioeconomic Factors

    Frontiers in Cardiovascular Medicine, Vol. 9

  3. Follow-up care of 12 months of patients with bladder cancer in Spain: A multicenter prospective cohort study

    Medicine (United States), Vol. 101, Núm. 42, pp. E31175

  4. Four-month incidence of suicidal thoughts and behaviors among healthcare workers after the first wave of the Spain COVID-19 pandemic

    Journal of Psychiatric Research, Vol. 149, pp. 10-17

  5. Mental impact of Covid-19 among Spanish healthcare workers. A large longitudinal survey

    Epidemiology and Psychiatric Sciences, Vol. 31

  6. Prevalence study of intermittent hormonal therapy of Prostate Cancer patients in Spain

    F1000Research, Vol. 10

  7. Reducing Unnecessary Treatment of Bronchiolitis Across a Large Regional Health Service in Spain

    Pediatrics, Vol. 150, Núm. 5

  8. Revascularized ST-segment elevation myocardial infarction. Temporal trends in contemporary therapies and impact on outcomes

    Revista Espanola de Cardiologia, Vol. 75, Núm. 8, pp. 659-668

  9. Sample size requirement in trials that use the composite endpoint major adverse cardiovascular events (MACE): new insights

    Trials, Vol. 23, Núm. 1